CLINICAL_TRIALS
trial_result
· 2025-02-24
Clinical Trial Update: LEO 29102 Single and Multiple Dose Study by Dermal Application [Phase 1]
Summary
Phase 1 study of LEO 29102 for atopic dermatitis, evaluating single and multiple dermal doses, has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED